{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-064804","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2026-06-03T21:00:52+00:00","discovered_at":"2026-06-03T21:02:00.238074+00:00","generated_at":"2026-06-03T21:09:03.160124+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Silo Pharma announces 1-for-15 reverse stock split effective June 2, 2026","bullets":["Every 15 shares of common stock combined into 1 share; par value unchanged at $0.0001.","Authorized shares reduced proportionately from 100M to approximately 6.67M.","Fractional shares rounded up to the next whole share; no fractional shares issued.","Common stock trades under same symbol SILO but with new CUSIP 82711P 300.","Split-adjusted trading began on The Nasdaq Capital Market on June 3, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-064804","json":"https://secwatch.observer/filing/0001213900-26-064804.json","markdown":"https://secwatch.observer/filing/0001213900-26-064804.md","text":"https://secwatch.observer/filing/0001213900-26-064804.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026064804/0001213900-26-064804-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026064804/ea0293111-8k_silo.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T21:09:03.160124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}